These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6976357)

  • 21. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
    Jotwani R; Gupta U; Watanabe K; Ueno K
    Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced bacterial dissemination and liver injury in CD14-deficient mice following a chronic abscess-forming peritonitis induced by Bacteroides fragilis.
    Woltmann A; Gangloff SC; Bruch HP; Rietschel ET; Solbach W; Silver J; Goyert SM
    Med Microbiol Immunol; 1999 Mar; 187(3):149-56. PubMed ID: 10206146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
    Onderdonk AB; Kasper DL; Cisneros RL; Bartlett JG
    J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.
    Chung DR; Kasper DL; Panzo RJ; Chitnis T; Grusby MJ; Sayegh MH; Tzianabos AO
    J Immunol; 2003 Feb; 170(4):1958-63. PubMed ID: 12574364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses.
    Tzianabos AO; Kasper DL; Onderdonk AB
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S132-40. PubMed ID: 7548535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber.
    Onderdonk AB; Cisneros RL; Crabb JH; Finberg RW; Kasper DL
    Infect Immun; 1989 Oct; 57(10):3030-7. PubMed ID: 2777372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization-induced changes in later intra-abdominal abscess formation are mediated by cellular and humoral mechanisms.
    Sawyer RG; Adams RB; Spengler MD; Pruett TL
    Curr Surg; 1990; 47(5):331-4. PubMed ID: 2257748
    [No Abstract]   [Full Text] [Related]  

  • 29. Virulence factors in Bacteroides fragilis group.
    Jotwani R; Gupta U
    Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum antibody response to Bacteroides fragilis in women with abscesses following hysterectomy.
    Polk BF; Kasper DL; Shapiro M; Tager IB; Schoenbaum SC; Goldstein PR
    Obstet Gynecol; 1980 Feb; 55(2):163-6. PubMed ID: 7352073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
    Kalka-Moll WM; Tzianabos AO; Wang Y; Carey VJ; Finberg RW; Onderdonk AB; Kasper DL
    J Immunol; 2000 Jan; 164(2):719-24. PubMed ID: 10623815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental intraabdominal abscess formation by Escherichia coli and bacteroides fragilis.
    Hagen JC; Wood WS; Hashimoto T
    Eur J Clin Microbiol; 1983 Feb; 2(1):43-9. PubMed ID: 6341050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis.
    Gibson FC; Onderdonk AB; Kasper DL; Tzianabos AO
    J Immunol; 1998 May; 160(10):5000-6. PubMed ID: 9590249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria.
    Tzianabos AO; Finberg RW; Wang Y; Chan M; Onderdonk AB; Jennings HJ; Kasper DL
    J Biol Chem; 2000 Mar; 275(10):6733-40. PubMed ID: 10702228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody response following subcutaneous and intraperitoneal injection of Bacteroides fragilis in rabbits.
    Landay ME
    Eur J Clin Microbiol; 1982 Aug; 1(4):248-51. PubMed ID: 7173187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro.
    Brubaker JO; Li Q; Tzianabos AO; Kasper DL; Finberg RW
    J Immunol; 1999 Feb; 162(4):2235-42. PubMed ID: 9973499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of a specific bacterial antigen in urine of rats with Bacteroides fragilis infection.
    Rissing JP; Buxton TB; Harris RW; Shockley RK; Craven P; Moore WL
    J Lab Clin Med; 1983 Sep; 102(3):392-9. PubMed ID: 6886522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of specific bacterial antigen in urine of patients infected with Bacteroides fragilis.
    Rissing JP; Buxton TB; Harris RW; Shockley RK
    J Infect Dis; 1984 Jun; 149(6):929-34. PubMed ID: 6736683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteroides fragilis-stimulated interleukin-10 contains expanding disease.
    Cohen-Poradosu R; McLoughlin RM; Lee JC; Kasper DL
    J Infect Dis; 2011 Aug; 204(3):363-71. PubMed ID: 21742834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.
    Tzianabos AO; Gibson FC; Cisneros RL; Kasper DL
    J Infect Dis; 1998 Jul; 178(1):200-6. PubMed ID: 9652441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.